All the news Showing 10 of 22 articles from: ItalyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources NAFLD Fatty liver disease raises the risk of cardiovascular disease in people with HIV Keith Alcorn / 28 March 2022 Non-alcoholic fatty liver disease or liver fibrosis raised the risk of cardiovascular disease in people with HIV who have either normal body weight or are under 60, Italian and Canadian ... Hepatocellular carcinoma (HCC) Some people remain at risk for liver cancer despite hepatitis C treatment Liz Highleyman / 22 December 2021 Some people with liver cirrhosis remain at risk for developing hepatocellular carcinoma (HCC) even after hepatitis C treatment, according to study results presented at The Liver Meeting. Not achieving a cure was the biggest ... Treatment in cirrhosis Liver function improves in most people with cirrhosis after hepatitis C cure Keith Alcorn / 18 May 2021 Most people with hepatitis C and liver cirrhosis experience improvement in liver function after direct-acting antiviral treatment, but a small minority – mainly those with a history of liver decompensation – may ... Liver transplants Liver transplants and COVID-19 Keith Alcorn / 28 April 2020 Liver specialists in New York report a high frequency of severe COVID-19 cases in organ transplant recipients who became infected with SARS-CoV-2, while Italian specialists report that 15 of 17 patients who underwent ... Treatment outcomes Does portal hypertension always improve after hepatitis C cure? Keith Alcorn / 10 May 2018 Although portal hypertension improves in the majority of people with hepatitis C and cirrhosis after hepatitis C is cured, not all people experience improvement, and oesophageal varices may continue to ... Hepatocellular carcinoma (HCC) Large Italian studies confirm no increase in liver cancer risk after hepatitis C treatment Keith Alcorn / 19 April 2018 Further research presented at this year’s International Liver Congress confirms that direct-acting antiviral (DAA) treatment leading to the cure of hepatitis C infection does not raise the risk of developing ... Treatment outcomes Curing hepatitis C reduces deaths and liver disease Keith Alcorn / 17 April 2018 Curing hepatitis C infection significantly reduces deaths from liver disease and reduces the incidence of decompensation, two large prospective studies from Italy and Scotland show. The findings were presented on ... Pan-genotypic regimens 8-week treatment for hepatitis C with Maviret highly effective in people without cirrhosis Keith Alcorn / 13 April 2018 An eight-week course of treatment with the combination of glecaprevir and pibrentasvir (Maviret) is highly effective in curing hepatitis C infection in people without cirrhosis, results of two real-world studies presented at the ... Hepatitis A Italian hepatitis A outbreak among MSM linked to two European strains Healio Hepatology / 13 April 2018 Treatment in cirrhosis Albumin reduces complications and improves survival in people with decompensated cirrhosis Liz Highleyman / 08 May 2017 Long-term administration of human albumin was associated with fewer serious complications, less hospitalisation, better quality of life and longer survival for people with decompensated liver cirrhosis, according to a report at the International ... ← First123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive